FCM
BHVN icon

Farallon Capital Management’s Biohaven BHVN Stock Holding History

Farallon Capital Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,813,167
Closed -$116M – 146
2025
Q1 		$116M Buy
4,813,167
+385,000
+9% +$13.6M 0.55% 43
2024
Q4 		$165M Buy
4,428,167
+785,578
+22% +$36.7M 0.73% 45
2024
Q3 		$182M Buy
3,642,589
+1,394,589
+62% +$54.3M 0.8% 45
2024
Q2 		$78M Buy
2,248,000
+1,449,000
+181% +$57.3M 0.33% 52
2024
Q1 		$43.7M Buy
799,000
+49,000
+7% +$2.43M 0.19% 60
2023
Q4 		$32.1M Hold
750,000
– – 0.15% 62
2023
Q3 		$19.5M Hold
750,000
– – 0.09% 75
2023
Q2 		$17.9M Hold
750,000
– – 0.09% 81
2023
Q1 		$10.2M Sell
750,000
-250,000
-25% -$3.98M 0.06% 98
2022
Q4 		$13.9M Buy
1,000,000
+759,595
+316% +$10.7M 0.08% 93
2022
Q3 		$1.48M Buy
+240,405
New +$1.74M 0.01% 210

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Farallon Capital Management's BHVN Position: Q2 2025 in Review

Farallon Capital Management sold out of Biohaven (BHVN) in Q2 2025, closing a stake of 4,813,167 shares — an estimated $116M sold.

Farallon Capital Management first reported a position in BHVN in Q3 2022 and held it in 11 quarters. The position peaked at $182M in Q3 2024. 249 funds tracked by Wall St. Rank hold BHVN as of Q2 2025.

  • Farallon Capital Management reported no remaining Biohaven position as of Q2 2025 after selling out during the quarter.
  • Farallon Capital Management sold 4,813,167 Biohaven shares in Q2 2025, an estimated $116M.
  • Farallon Capital Management first reported a position in Biohaven in Q3 2022 and held it in 11 quarters.
  • Farallon Capital Management's Biohaven position peaked at $182M in Q3 2024.
  • 249 funds tracked by Wall St. Rank held Biohaven as of Q2 2025.

Based on Farallon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.